Morbus Alzheimer’s may be reversible after all?

Prof. Ulrich Sprick interviewed by Mona Elzayat, MSc, Austrian “PatientInnenportal”

Prof. Dr. med. Dr. rer. nat. Ulrich Sprick, chief physician of the outpatient services of the day clinics at the Alexius/Josef Hospital in Neuss and lecturer at the Heinrich Heine University Düsseldorf (HHU) is, dedicates himself intensively to the research of Transcranial Pulse Stimulation (TPS). In a digital conversation with Mona Elzayat, MSc, head of the Austrian “PatientInnenportal”, he presented last week facts about the current state of research of shock wave therapy TPS, reported on the findings of the mechanisms of action and evaluated the high potential of this therapy for patient:inside with an Alzheimer diagnosis.

In the interview, the scientist particularly emphasized the high safety and tolerability of this novel brain stimulation procedure and postulated that established doctrinal opinions may soon be reconsidered in future reference books: <The textbooks say that Alzheimer’s disease is a progressive disease that keeps progressing and that it is irreversible. We are about to scratch that irreversibility!><, Prof. Sprick expressed.”

The synergistic effect of Transcranial Pulse Stimulation in combination with pharmacological interventions for Alzheimer’s patient:in is currently being intensively studied by Prof. Sprick’s teams as well as by other scientific institutions worldwide. Results to date indicate that TPS offers the potential to optimize and expand individualized treatment approaches for affected individuals.

Mona Elzayat, who is a member of the board of the “Patient Portal” – a platform that provides up-to-date medical and psychological information for people with oncological, chronic and rare diseases and whose scientific advisory board consists of renowned scientists from the University of Vienna – emphasizes the relevance of this topic. She resumes, <<Morbus Alzheimer’s is among the chronic diseases and it would be desirable if soon there would actually be the long-awaited breakthroughs in research that could help those affected.>>

The interview can be viewed in German as well as read on the blog in German. Translations of the transcription in English, Spanish and Turkish can be found below as pdfs.

Links to the interview:

The 20-minute interview from October 05, 2023 can be seen on the following channels:

Patient Portal:



To read the interview in German, click here:

Translations of the interview in English, Spanish and Turkish in pdf format can be found here:




© Mona Elzayat, – 2023